Clinical trial

Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC

NCT05754203

Study summary

ClinicalTrials.gov

Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

RADIATION · Unmapped registry intervention Super-hyperfractionation Pulse Radiotherapy Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-08-01

PhaseNA

Conditions

Lung Cancerverified · MONDO: lung cancer

Immune Checkpoint Inhibitorunresolved

Radiotherapyunresolved

Interventions

Super-hyperfractionation Pulse RadiotherapyRADIATION

Sponsors & collaborators

Xinqiao Hospital of Chongqinglead sponsor

Mapped research locations

ChongqingChongqing Municipality, China1 ChongqingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05754203 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.